FDA Defends Approvals After Divided Advisory Committee Votes In JAMA
Executive Summary
FDA must continue to approve products when there is scientific disagreement evidenced by split advisory committee votes, agency officials declared in the Dec. 22/29 issue of the Journal of the American Medical Association.